Skip to main content
. 2025 Oct 28;24(2):254. doi: 10.1007/s40200-025-01763-w

Table 4.

Temporal trend for DR screening by MBS item across age groups per 100,000 people with diabetes*

2016 to 2017 2017 to 2018 2018 to 2019 2019 to 2020 2020 to 2021 2021 to 2022 2022 to 2023 2023 to 2024
< 25 years
MBS 12,326 40 220 459 499 180 279 439 339
MBS 12,325 120 459 659 579 758 279 299 379
Total 160 679 1118 1078 938 558 738 718
25–44 years
MBS 12,326 16 46 84 182 137 119 116 52
MBS 12,325 42 140 183 133 149 82 90 99
Total 58 186 267 315 286 201 206 151
45–64 years
MBS 12,326 23 56 85 151 102 81 97 44
MBS 12,325 33 93 158 122 117 69 69 89
Total 56 149 243 273 219 150 166 133
65–74 years
MBS 12,326 21 67 67 139 96 74 99 50
MBS 12,325 12 53 64 51 60 40 37 40
Total 33 120 131 190 156 114 136 90
≥ 75 years
MBS 12,326 18 39 40 73 41 33 54 26
MBS 12,325 3 21 21 19 17 14 10 11
Total 21 60 61 92 58 47 64 37

*Three states (TAS, NT & ACT) were excluded as age-group-wise diabetes prevalence data were not available for those states